title: Mutational analysis of early region 4 of bovine adenovirus type 3.
abstract: The primary objective of characterizing bovine adenovirus type 3 (BAV3) in greater detail is to develop it as a vector for gene therapy and vaccination of humans and animals. A series of BAV3 early region 4 (E4) deletion-mutant viruses, containing deletions in individual E4 open reading frames (Orf) or combinations of Orfs, were generated by transfecting primary fetal bovine retinal cells with E4-modified genomic DNA. Each of these mutants was further analyzed for growth kinetics, viral DNA accumulation, and early-late protein synthesis. Mutant viruses carrying deletions in Orf1, Orf2, Orf3, or Orf4 showed growth characteristics similar to those of the E3-deleted BAV3 (BAV302). DNA accumulation and early/late protein synthesis were also indistinguishable from those of BAV302. However, mutant viruses carrying a deletion in Orf5, Orfs 1-3 (BAV429), or Orfs 3-5 (BAV430) were modestly compromised in their ability to grow in bovine cells and express early/late proteins. E4 mutants containing larger deletions, Orfs 1-3 (BAV429) and Orfs 3-5 (BAV430), were further tested in a cotton rat model. Both mutants replicated as efficiently as BAV3 or BAV302 in the lungs of cotton rats. BAV3-specific IgA and IgG responses were detected in serum and at the mucosal surfaces in cotton rats inoculated with mutant viruses. In vitro and in vivo characterization of these E4 mutants suggests that none of the individual E4 Orfs are essential for viral replication. Moreover, successful deletion of a 1.5-kb fragment in the BAV3 E4 region increased the available insertion capacity of replication-competent BAV3 vector (E3-E4 deleted) to approximately 4.5 kb and that of replication-defective BAV3 vector (E1a-E3-E4 deleted) to approximately 5.0 kb. This is extremely useful for the construction of BAV3 vectors that express multiple genes and/or regulatory elements for gene therapy and vaccination.
authors.affiliation: Virology Group, Veterinary Infectious Diseases Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E3.
authors.forename: M K
authors.initials: MK
authors.lastname: Baxi
authors.forename: J
authors.initials: J
authors.lastname: Robertson
authors.forename: L A
authors.initials: LA
authors.lastname: Babiuk
authors.forename: S K
authors.initials: SK
authors.lastname: Tikoo
mesh_terms: D000257:Adenoviridae Infections / Q000097:blood / Q000276:immunology / Q000821:virology; D017504:Adenovirus E4 Proteins / Q000235:genetics* / Q000276:immunology / Q000502:physiology; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002417:Cattle; D004195:Disease Models, Animal; D005814:Genes, Viral / Q000502:physiology*; D017921:Mastadenovirus / Q000235:genetics* / Q000276:immunology / Q000502:physiology; D016296:Mutagenesis; D016366:Open Reading Frames / Q000502:physiology*; D051381:Rats; D012141:Respiratory Tract Infections / Q000097:blood / Q000276:immunology / Q000821:virology; D016205:Sigmodontinae; D014764:Viral Proteins / Q000235:genetics* / Q000276:immunology / Q000502:physiology; D014779:Virus Replication
chemical_list: D017504:Adenovirus E4 Proteins; D000914:Antibodies, Viral; C121517:E4orf4 protein, adenovirus; D014764:Viral Proteins